PMV Pharmaceuticals Inc. is a high-risk pharmaceutical company in the United States, specializing in precision oncology. They focus on developing small molecule therapies that target p53 mutations to eliminate cancer cells. With an ESG score of 31.6, PMV Pharmaceuticals is committed to environmental sustainability and good governance practices in the healthcare industry.